AZN
The table below shows AstraZeneca PLC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $21.24B | $21.02B | $20.05B | $19.82B | $20.00B | $11.85B |
| Total assets | $114.07B | $104.03B | $101.12B | $96.48B | $105.36B | $66.73B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | - | - | - | - | - | - |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $65.36B | $63.16B | $61.95B | $59.42B | $66.08B | $51.09B |
| Retained earnings | - | - | - | - | - | - |
| Total equity | - | - | - | - | - | - |